Nemocnice Horovice

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Prostate cancer2 trials
• Colorectal cancer1 trial
• Crohn's disease1 trial
• Liver and biliary tract cancer1 trial
• Metastatic breast cancer1 trial
• Ovarian cancer1 trial

Phase

• Phase 33 trials
• Phase 22 trials

Status

• Active, not recruiting2 trials
• Completed1 trial
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• Hoffmann-La Roche1 trial
• SOTIO Biotech AG1 trial
• Zai Lab (Shanghai) Co., Ltd.1 trial

Running trials

• Recruiting

  A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

  NCT07218146· Phase 3· Zai Lab (Shanghai) Co., Ltd.· Source

• Active, not recruiting

  A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)

  NCT05288166· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

  NCT04975308· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting

Closed trials

• Active, not recruiting

  Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease

  NCT05910528· Phase 2· Hoffmann-La Roche· Source

• Terminated

  A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

  NCT05256381· Phase 2· SOTIO Biotech AG· Source